Europe Neonatal Ventilators Market Research Report 2026-2031

The Europe neonatal ventilators market is expected to grow at a CAGR of 4.11% from 2025 to 2031.

KEY TAKEAWAYS

• Component: The consumables & accessories segment accounted for the largest market share of around 60%.
• Functionality: The non-invasive neonatal ventilation segment shows significant growth, with the fastest-growing CAGR of 5.17% during the forecast period
• Mobility: In 2025, the standalone segment holds the largest Europe neonatal ventilators market share.
• End-User: The hospital segment accounted for the largest market share.
• Region: Germany was the largest revenue contributor with over 15% market share.

Recent Developments in Europe Neo Ventilators Market

• In January 2025, Hamilton Medical launched HAMILTON HF90. It is offering a complete solution for high-flow oxygen therapy. It is an all in one device that helps to enhance patient comfort and support mobility.
• In February 2024, Getinge AB introduced Servo TwinView, a web-based platform that allows clinicians to monitor ventilator metrics from a distance.

Mergers & Acquisitions

• In July 2025, Philips formed strategic alliances with four major critical care firms - Getinge, Dräger, Hamilton Medical, and infusion technology leader B. Braun to optimize clinical workflows and improve patient care environments.

EUROPE NEONATAL VENTILATORS MARKET TRENDS

Technological Advancements

Technological advancements are a key trend in the neonatal-ventilators market. This trend is majorly driven by factors including focus on improving survival rates, clinician workload & staff shortages, need to mitigate lung injury, modernisation of infrastructure, integration with quality dashboards & hospital IT, and rising incidence to preterm births. Modern neonatal ventilators leverage cutting-edge technology to prioritize lung-protective care, specifically designed to safeguard the delicate physiology of premature babies while reducing the incidence of chronic conditions like Bronchopulmonary Dysplasia (BPD). Recent technological advancements include adaptive & intelligent ventilation algorithms, non-invasive ventilation (NIV) enhancements, integrated monitoring & connectivity, transport optimization, graphical interfaces & decision support tools, synchronized patient triggering, etc. Modern medical advancements reduce the workload for clinical teams while maintaining precise, stable oxygenation for neonates. By offering diverse ventilation modes within a single platform, these devices allow for seamless transitions between therapies, optimizing efficiency during critical emergency interventions. Thus, advancement in technologies will be expected to drive the demand for neo ventilators in the European market during the forecast period.

Universal Ventilator Platforms

The European neonatal respiratory sector is seeing an evolution of a move towards universal ventilation platforms. This shift is motivated by the medical community's demand for greater clinical adaptability and the desire to streamline hospital workflows. By catering to diverse age groups, ranging from micro-preemies to adults, these adaptive systems offer hospitals greater clinical flexibility and cost-effectiveness. The companies are creating ventilators with extensive therapeutic versatility, enabling a single unit to serve diverse patient groups and adapt to multiple clinical environments. These adaptable systems facilitate a seamless transition between stationary bedside care and emergency transport across various hospital departments.

EUROPE NEONATAL VENTILATORS MARKET DRIVERS

Growing Demand for Minimally Invasive Treatments

Growing demand for minimally invasive treatments acts as a primary catalyst for the European neo ventilators market. It is driven by several factors that include technological integration, improved patient tolerance, ease of use & workflow, and reduction of chronic complications. Minimally invasive treatment methods in ventilation, specifically Bubble CPAP and High-Flow Nasal Cannula (HFNC)are preferred for their intuitive design, helping hospitals manage staffing gaps where specialized respiratory experts are scarce. By removing the need for an endotracheal tube, infants require fewer sedatives, which encourages immediate maternal bonding and the practice of Kangaroo Mother Care. Current European protocols for treating Respiratory Distress Syndrome (RDS) now advocate for Less Invasive Surfactant Administration (LISA). This method enables the delivery of surfactant while the infant is supported by non-invasive ventilation, such as CPAP.

Government & NGO Programs to Reduce Infant Mortality

Government & NGO Programs to reduce infant mortality are a major driver in the Europe neo ventilators market. It is driven by several factors that include NGO-led crisis reliance, direct procurement & subsidies, funding for R&D, financial risk mitigation, and infrastructure expansion. Major European powers, including France, Germany, and the UK, are focusing on improving newborn survival rates by providing substantial funding for the upgrade of intensive care facilities. Simultaneously, developmental initiatives supported by the European Union are facilitating the acquisition of high-end respiratory devices in Eastern Europe to align their medical capabilities with Western standards. The demand for sophisticated neonatal ventilators is rising as a direct result of government-backed initiatives to better equip and expand NICUs and NBSUs. By strengthening healthcare infrastructure through increased funding, authorities are ensuring that life-saving ventilation equipment is a staple in newly established newborn care centers.

INDUSTRY RESTRAINTS

Training & Skilled Staff Shortage

Training & Skilled Staff Shortage is one of the major challenges in the Europe neo ventilators market. It is due to the limited number of trained NICU professionals globally, limited neonatal ventilation is complex & high-risk, fear of misuse & legal risk, uneven distribution of killed staff, and high training & retaining costs. A lack of educational resources in low-income areas serves as a bottleneck for regional growth, as there are few experts available to train on-site staff. Consequently, the high-end features of modern respiratory systems often go unused, with operators defaulting to basic modes. This has forced vendors to integrate comprehensive clinical training packages into their sales models to ensure that advanced equipment can be utilized to its full potential. The sophisticated nature of technologies like High-Frequency Jet Ventilation (HFJV) demands an expert grasp of infant lung physiology. Because many facilities lack seasoned respiratory therapists or neonatologists, the use of such advanced hardware is often restricted to top-tier tertiary hospitals, limiting its reach in smaller clinics. A shortage of proficient healthcare professionals often compromises the standard of neonatal care, negatively impacting clinical outcomes and parental trust. Consequently, the challenge of recruiting a qualified workforce acts as a significant bottleneck, potentially stalling the adoption and market expansion of neo ventilators.

EUROPE NEONATAL VENTILATORS MARKET SEGMENTATION INSIGHTS

INSIGHT BY COMPONENT

The Europe neonatal ventilators market by component is segmented into consumables & accessories and devices. The consumables & accessories segment accounted for the largest market share of around 60%. The segment growth is a mature and stable market supported by strong neonatal care systems and high healthcare spending, though declining birth rates limit volume growth. This segment is experiencing an accelerating growth as the clinics and hospitals are focused on patient-specific and infection control interfaces for avoiding cross-contamination.

Although the consumables and accessories are low-cost, but it generate higher revenue and margin, as it required for each replaced ventilator and each patient. Adoption of specific consumables, such as low-dead-space circuits or specific nasal prongs, is driven by evidence around lowering nasal injury and clinician comfort.

INSIGHT BY FUNCTIONALITY

Based on the functionality, the non-invasive neonatal ventilation segment shows significant growth, with the fastest-growing CAGR of 5.17% during the forecast period, as clinicians prioritise lung-protective strategies, reduced intubation-related complications, and improved neonatal outcomes. The non-invasive modes include CPAP, BiPAP, high-flow nasal cannula therapy, and nasal intermittent positive pressure ventilation (NIPPV), allowing clinicians to provide continuous or intermittent support while preserving spontaneous breathing.

By eliminating the necessity for intubation, non-invasive methods markedly decrease the likelihood of respiratory tract injuries and healthcare-associated infections typically linked to invasive procedures. It fuels the growth of non-invasive ventilators in the European markets.

INSIGHT BY MOBILITY

In 2025, the standalone segment holds the largest Europe neonatal ventilators market share. Standalone units command the largest device price, along with multi-year installation/service contracts. These ventilators are sophisticated, high-capacity machines engineered to provide continuous, intensive respiratory care for newborns within the NICU environment.

Standalone neo ventilators are typically preferred in hospital settings due to their comprehensive features, high precision, and ability to support critically ill neonates requiring long-term respiratory assistance.

The portable neo ventilators segment is fast-growing in the mobility segmentation. Portable neo ventilators are battery-operated or lightweight, designed for intrahospital transport, for low resource care settings, pr interfacility transfer by air/ambulance. Hospitals are increasingly equipping transport/ambulance teams and also remote clinics with portable ventilators.

INSIGHT BY END-USER

The Europe neonatal ventilators market by end user is segregated into hospitals, maternity & speciality care, and other users. The hospital segment accounted for the largest market share. It is driven by several factors includes the government funding for upgrading ageing ventilators, the growing number of ICU admissions for Neonates, and increasing high-risk pregnancies, which require immediate hospitalization as per the NICU stabilization. In 2023, there were almost 2.3 million hospital beds available across the EU.

These centers require neo ventilators with pressure/volume targeting, closed-loop features, leak compensation, and advanced monitoring. High patient throughput helps to generate the recurring revenue from filters, interfaces, and circuits.

The consistent growth of Neonatal Intensive Care Unit (NICU) capacity across Europe, necessitated by a rising frequency of premature births, is a primary driver for equipment demand. The hospitals spend more money on buying advanced multi-mode neo ventilators and make a purchase, including training, spare parts, and extended warranties. There is a rising demand for AI-enabled early warning systems for infection and apnea detection.

EUROPE NEO VENTILATORS MARKET REGIONAL ANALYSIS

Europe neonatal ventilators market represent second largest market globally and characterized by the current shift towards non-invasive, automated, and lung-protective respiratory technologies. The market is driven by technological advancements & automation, rising incidence of preterm births, government healthcare initiatives, funding programs, shift towards home-based care, and national neonatal care policies. Approximately 500,000 babies are born each year prematurely in Europe. Affects roughly 10% of all births, making it the largest child patient group in Europe.

Germany was the largest revenue contributor with over 15% market share, followed by the UK, France and other countries. Germany’s growth is driven by several factors includes strong domestic OEM base, low fertility trends, tight hospital procurement cycles, well-funded hospital systems, and a focus on evidence, & training-based ventilation in tertiary centers.

The UK is a fast-growing country in the Europe neonatal ventilators market. It is driven by several factors includes emphasis on cost-effectiveness & consumables cost control, active clinical research & adoption of closed-loop ventilation, strong neonatal transport networks, a large NHS market with centralised procurement cycles, and Brexit-era registration complexity, encouraging the suppliers.

The introduction of UK legislation providing up to 12 weeks of statutory neonatal care leave for parents of babies requiring at least one week in intensive care reflects growing recognition of neonatal care needs, supporting investments in advanced NICU infrastructure.

Regulatory frameworks, including the UKCA requirements under the MHRA and NHS procurement standards, are strengthening product quality, clinical safety, and post-market surveillance for neonatal ventilators. These regulations are encouraging manufacturers to enhance clinical validation, energy efficiency, and lifecycle compliance of neonatal ventilation systems, while supporting the adoption of advanced non-invasive and NAVA-enabled technologies across UK NICUs.

EUROPE NEO VENTILATORS MARKET VENDOR LANDSCAPE

The Europe neonatal ventilators market is having fragmented landscape. The leading players have massive installed bases in NICUs. They are having string global distribution network. The leading players in this market are not just selling the neo ventilators, but they are selling integrated NICU solutions, which include AI-driven data platforms, patient monitors, etc. The stringent regulatory requirements and high R&D costs create a moat that protects established players from new entrants in the Europe neo ventilators market. The leading players are focusing on adopting AI & Automation and leading the race with closed-loop ventilators. This ventilator automatically adjusts pressure and oxygen levels as per the baby’s real-time needs. The Chinese brands are offering neo ventilators at a lower price point with premium features, which is creating a significant challenge for Western brands in the emerging markets of Europe.

Key Vendors

• Dragerwerk AG & Co. KGaA
• GE Healthcare Technologies Inc.
• Getinge AB
• Hamilton Medical
• Inspiration Healthcare Group plc.
• Koninklijke Philips N.V.

Other Prominent Vendors

• Air Liquide
• ATOM MEDICAL Corp.
• Bunnell Incorporated
• Fritz Stephan GmbH
• ICU Medical, Inc.
• Leistung Equipamentos LTDA
• Lowenstein Medical SE & Co. KG
• Max Meditech Pvt. Ltd.
• Metran Co., Ltd.
• Nihon Kohden Corporation
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Zoll Medical Corporation

Segmentation by Component

• Consumables & Accessories
• Devices

Segmentation by Functionality

• Non-invasive
• Hybrid

Segmentation by Mobility

• Standalone
• Portable

Segmentation by End-User

• Hospitals
• Maternity & Specialty Care
• Other Users

Segmentation by Geography

• EUROPE
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Poland
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Austria
  • Portugal

KEY QUESTIONS ANSWERED

1. Which functionality segment provides more business opportunities in the Europe neonatal ventilators market?
2. What is the growth rate of the Europe neonatal ventilators market?
3. Which country dominates the Neonatal ventilators market in Europe?
4. How big is the Europe neonatal ventilators market?
5. Who are the major players in the Europe neonatal ventilators market?